MicroConstants

MICROCONSTANTS WELCOMES A NEW IMMUNOLOGY MANAGER AND ANNOUNCES THE EXPANSION OF IMMUNOLOGY SERVICES

SAN DIEGO, CA, August 10, 2011 - MicroConstants, Inc., a bioanalytical and pharmacokinetic specialty Contract Research Organization (CRO) in San Diego, announces the appointment of Lilin Wang as the new manager of their Immunology Department. Lilin brings to MicroConstants more than 18 years of experience developing immunological and molecular assays to support preclinical and clinical drug development studies. His expertise will enable the Company to provide additional contract research services to pharmaceutical and biotech companies developing large molecule drugs and other biologics.

MICROCONSTANTS CHINA RECEIVES ENDORSEMENT OF OECD GLP COMPLIANCE

BEIJING, CHINA, May 26, 2011 - MicroConstants China Inc., a Contract Research Organization (CRO) conducting preclinical pharmacokinetics studies and providing full-service early stage clinical trial management in Beijing, announces the Endorsement of Compliance with the OECD Principles of Good Laboratory Practice (GLP) in the areas of analytical chemistry and pharmacokinetic studies from the Netherlands GLP Compliance Monitoring Programme. MicroConstants China is the first test facility in China to receive an Endorsement of GLP Compliance from the Netherlands inspectorate.

MICROCONSTANTS COMPLETES INSTALLATION OF LATEST LC/MS/MS TECHNOLOGY TO ACHIEVE IMPROVED SENSITIVITY IN BIOANALYTICAL METHOD DEVELOPMENT

SAN DIEGO, CA, March 2, 2011 - MicroConstants, Inc., a bioanalytical and pharmacokinetic-specialty Contract Research Organization (CRO) in San Diego, California, announces today that it has successfully completed the installation and qualification of a new Xevo® TQ-S tandem mass spectrometer from Waters Corporation. The unparalleled speed, sensitivity and accuracy of this new LC/MS/MS system will allow MicroConstants to quantify compounds at lower concentrations than previously possible and enable the development of more robust bioanalytical methods for even the most analytically complex compounds.

MICROCONSTANTS CHINA RECEIVES CNAS (ISO-17025) ACCREDITATION

BEIJING, CHINA, November 5, 2010 - MicroConstants China Inc., a Contract Research Organization (CRO) specializing in preclinical and clinical pharmacokinetics contract research, announces the accreditation of its bioanalytical laboratory by the China National Accreditation Service for Conformity Assessment (CNAS), a Chinese government agency that monitors quality systems of analytical laboratories based on ISO-17025 guidelines.

MICROCONSTANTS CELEBRATES NATIONAL CHEMISTRY WEEK BY TEACHING SAN DIEGO
HIGH SCHOOL STUDENTS ABOUT THE DRUG DEVELOPMENT PROCESS

SAN DIEGO, CA, October 21, 2010 - In honor of National Chemistry Week (NCW), MicroConstants, a bioanalytical and pharmacokinetic-specialty Contract Research Organization (CRO) in San Diego, California, has joined with Herbert Hoover High School to help raise awareness of the significance of chemistry in our everyday lives.

National Chemistry Week is a community-based annual event organized by the American Chemical Society (ACS) to unite local ACS sections, businesses, schools and individuals in communicating the importance of chemistry to our quality of life. This year, MicroConstants is participating by demonstrating to local high school students the roles that chemistry and chemists play in developing new drugs to fight disease and help improve people’s lives everyday. The goal is to show students at Hoover High that studying chemistry can lead to many exciting careers and opportunities. MicroConstants will also be donating laboratory equipment to Hoover High’s science department to provide students with some of the supplies they need to support their chemistry education.

MICROCONSTANTS EXPANDS ITS GLP BIOANALYTICAL CAPACITY AND BROADENS BUSINESS DEVELOPMENT EFFORTS INTO THE EAST COAST

SAN DIEGO, CA, June 10, 2010 - MicroConstants, Inc., a bioanalytical and pharmacokinetic-specialty Contract Research Organization (CRO) in San Diego, California, announces the continued expansion of its bioanalytical capacity through the addition of a second Waters Xevo TQ MS system. The CRO has also appointed a new East Coast business development manager to actively pursue new business opportunities in that region.

MICROCONSTANTS CHINA ENTERS COLLABORATION AGREEMENT WITH INSTITUTE OF
ZOOLOGY, KUNMING TO PROMOTE PRIMATE RESEARCH AND DEVELOP NOVEL DRUG CANDIDATES

KUNMING, CHINA, April 30, 2010 - MicroConstants China Inc., a Contract Research Organization (CRO) specializing in preclinical and clinical pharmacokinetics contract research, announces the signing of a collaboration agreement with the Kunming Institute of Zoology (KIZ), Chinese Academy of Science. The agreement will establish a new Technology Commercialization Center of Kunming Institute of Zoology and designates MicroConstants China as the project manager for the development and out-licensing of KIZ’s novel drug candidates globally.

MICROCONSTANTS NOW OFFERS NANOPARTICLE FORMULATION SERVICES

Unveils New Service Offering at the Society of Toxicology’s 2010 Annual Meeting & ToxExpo™

SALT LAKE CITY, UTAH, March 8, 2010 - MicroConstants, a GLP-compliant Contract Research Organization (CRO) specializing in bioanalytical and pharmacokinetic analysis, has acquired access to a new nanosizing technology that transforms water insoluble compounds into nanoparticles, making formulation preparation and dosing for toxicology studies easier. In multiple cases, the method has been proven to increase the gastro-intestinal absorption of highly insoluble compounds ensuring maximal oral exposure for toxicology studies.

MICROCONSTANTS CHINA PARTICIPATES IN THE NIH CLINICAL PHARMACOLOGY TRAINING PROGRAM

David Yang, president of MicroConstants China, discusses regulatory policies, clinical pharmacology and drug development strategy for Chinese biotech companies

BEIJING, CHINA, November 20, 2009 - MicroConstants China Inc., a Contract Research Organization (CRO) specializing in bioanalysis and pharmacokinetics, announces their participation in the National Institute of Health’s (NIH) Principles of Clinical Pharmacology training program in Beijing, China. Dr. Q. David Yang, president of MicroConstants China, was a panelist at the event, and several MicroConstants employees assisted NIH experts by providing translation services during the training program.

MICROCONSTANTS WELCOMES RON SHEVOCK AS DIRECTOR OF BUSINESS DEVELOPMENT

SAN DIEGO, CA, November 2, 2009 - MicroConstants, Inc., a San Diego-based Contract Research Organization (CRO), today announced the appointment of Ron Shevock as their new director of business development. Ron, a former business development manager for a pharmaceutical product development company, has extensive experience selling contract research services to pharmaceutical and biotech companies at all stages of drug development.

MICROCONSTANTS, INC. ANNOUNCES THE USFDA AND OECD GLP-COMPLIANCE OF ITS BEIJING BIOANALYTICAL FACILITY

BEIJING, CHINA, March 24, 2009 - MicroConstants, Inc., a bioanalytical and pharmacokinetic-specialty Contract Research Organization (CRO) based in San Diego, California, announces today that its Beijing bioanalytical laboratory has met USFDA Good Laboratory Practice (GLP) requirements. MicroConstants China Inc. offers DMPK and bioanalytical contract research services to domestic and international pharmaceutical companies conducting preclinical and clinical studies in China. The establishment of the Beijing bioanalytical lab will eliminate the need for transferring valuable clinical samples across national borders.

MICROCONSTANTS ANNOUNCES THE ADDITION OF A QTOF LC/MS/MS SYSTEM

SAN DIEGO, CA, February 4, 2009 - MicroConstants, a bioanalytical and pharmacokinetic-specialty Contract Research Organization (CRO) based in San Diego, California, announces today that it has successfully completed the installation and qualification of a Micromass QTof mass spectrometer system from Waters.

News